Baxter Reports Third-Quarter 2026 Results

Third-quarter sales of $2.98 billion increased 5% on both a reported and organic basis,1, 2 reflecting growth in all segments and divisions Third-quarter U.S. GAAP3 diluted earnings per share (EPS) of $0.57;